Nalaganje...
PACE4-Based Molecular Targeting of Prostate Cancer Using an Engineered (64)Cu-Radiolabeled Peptide Inhibitor()()
The potential of PACE4 as a pharmacological target in prostate cancer has been demonstrated as this proprotein convertase is strongly overexpressed in human prostate cancer tissues and its inhibition, using molecular or pharmacological approaches, results in reduced cell proliferation and tumor prog...
Shranjeno v:
| izdano v: | Neoplasia |
|---|---|
| Main Authors: | , , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Neoplasia Press
2014
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4235008/ https://ncbi.nlm.nih.gov/pubmed/25220591 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.neo.2014.07.010 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|